https://www.selleckchem.com/pr....oducts/pf-07220060.h
eat potential for predicting pCR BC patients. The inflammatory response is extremely important in tumor progression, and it is very difficult to identify prognostic indicators for neoadjuvant therapy in breast cancer patients. The aim of this study was to mine the potential prognostic significance of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in breast cancer patients receiving anthracycline- or taxane-based neoadjuvant chemotherapy (NACT). A total of 67 women diagnosed with breast cancer who rec
Curtir
Comentario
Compartilhar
